Income statement

You can view the income statement here.

• Biographies
• Meetings & Events
• Clinical Publications
• Investor Relations
  • Stock Information
  • News & Events
    • Cardima, Inc. Receives Chinese State Food and Drug Administration (SFDA) Approval to Market the Intellitemp^® Energy Management Device in the People's Republic of China
    • Cardima’s Surgical Ablation Technology in the News
    • Cardima Appoints Japan Lifeline as its Distribution Partner in Japan for Pathfinder Diagnostic Line of Catheters
    • Cardima at Cardiostim June 18-21, 2008: Dr. Sanjeev Saksena Will Speak on Linear Ablation at Cardiostim Highlighting Cardima's EP and Surgical Programs
    • Dr. Jaswinder Gill, MD, FRCP to Present at the First Annual Europe AF Symposium, London, England on June 15, 2008
    • Atrial Fibrillation Data from UK Study Evaluating the Cardima EP Ablation System
    • Cardima Announces New Strategic Distribution Relationship with DOT Medical Ltd. for UK Electrophysiology Market
    • Cardima Announces Completion of $5 Million Private Placement
    • Cardima Announces Appointment of Dr. Abraham G. Kocheril to Scientific Advisory Board
    • Cardima Announces Appointment of Dr. Sanjeev Saksena to Scientific Advisory Board as FDA Regulatory Consultant
    • Cardima Announces Official Market Launch of the Surgical Ablation System at the 44th Annual Meeting of the Society of Thoracic Surgeons
    • Cardima Announces Strategic Marketing Agreement with ON-X Life Technologies Inc. for US Surgical Atrial Fibrillation (AF) Market
    • Cardima Showcases Mapping and Ablation Products at the 13th International Boston Atrial Fibrillation Symposium
    • Cardima Completes First Successful Cases in Thailand and Commences Training Program with Dr. Li Poa
    • Cardima Announces Appointment of Dr. Li Poa to Scientific Advisory Board as Surgical Consultant
    • Cardima Announces Completion of $9 Million Private Placement
    • Cardima and Stamford Hospital Medical Center Partner to Establish Surgical Ablation Training Program and Center of Excellence
    • Cardima Launches New 24-Electrode Surgical Ablation Probe and Completes First Case Series at Enloe Medical Center
    • Cardima Appoints Dr. Sung Chun as Chief Medical Officer
    • Cardima Announces Departure of Dr. Arjun Sharma
    • Cardima Appoints Dr. Arjun Sharma as Chief Medical Officer
    • Cardima Announces Patent for Intellitemp® Energy Management Device
    • Cardima Announces Resignation of Directors and Appointment of New Board Members
    • Cardima Announces Debt Settlement Agreement
    • Cardima Announces One-for-Ten Reverse Stock Split
    • Cardima Presents Linear Ablation Technologies at the 5th China Atrial Fibrillation Symposium Held in Beijing
    • Cardima Shareholders Approve All Proposals at Annual Meeting
    • Cardima Announces First Human Procedure Successfully Performed using Standard Thorascopic Techniques with 20-Electrode Irrigated Surgical Ablation Probe
    • FDA Dispute Resolution Panel Recommends to Not Approve REVELATION^® Tx Microcatheter System
    • Cardima PMA for Treatment of Atrial Fibrillation Symptoms to Be Reviewed by FDA Dispute Resolution Panel
    • Cardima Showcases Next Generation Ablation System at the CardioRhythm 2007 Conference in Hong Kong
    • Cardima to Host Scientific Symposium at the CardioRhythm 2007 Conference in Hong Kong on Sunday, February 4th, 2007
    • Form 8-K for Cardima Inc
    • Income Statement
    • Form 10QSB for Cardima Inc
    • Form 10QSB for Cardima Inc
    • Form 8-K for Cardima Inc
    • Cardima Shareholders Approve All Proposals at Annual Meeting
    • FDA Grants Review of Issues Pertaining to Cardima's REVELATION^® Tx PMA
    • Cardima Inc Files SEC Form 8-K, Other Events, Financial Statements and Exhibits
    • Cardima Receives FDA Market Clearance for New Surgical Ablation System
    • CORRECTING and REPLACING Cardima Enters Into $3 Million Loan Agreement
    • Cardima Establishes Strategic Surgical Market Relationship with Biocore and Extends Electrophysiology Partnership
    • Cardima Executes $6 Million Loan Agreement
    • Cardima Receives Market Approval for Thailand: Focus is on Establishing Centers of Excellence and the Tourist Medicine Market
    • Cardima Signs Peerless Medical as Distributor for the Midwest Surgical Market
    • Cardima Engages Western Medical as Distributor for Southern California, Arizona, and Nevada Surgical and Electrophysiology Markets
    • Cardima to Host Symposium at 45th Annual Meeting of the Society of Thoracic Surgeons and Showcase Products and Technologies at Conferences in San Francisco and Boston
    • Cardima Completes Second Atrial Fibrillation Training Session in Thailand
    • Cardima Completes $20 Million Private Placement
    • Cardima Appoints DKSH Healthcare to Distribute its Surgical Ablation System and EP Products in Thailand
    • Precision IR LHA Life Sciences & Med Tech Conference Webcast To Be Held on Thursday, March 26, 2009
    • Cardima Receives CE Mark Approval for its Surgical Ablation Probe with Stabilization Sheath
    • Cardima Exhibits at Surgical Tradeshows - ACTS and AATS
    • Cardima Surgical Ablation Training Course - October 23, 2009 - San Francisco, CA
    • Cardima Provides Business Update
    • Cardima’s PATHFINDER^® Diagnostic Catheters Receive Marketing Approval in Japan
    • Cardima Appoints Dr. Peter Wong to Board of Directors - Announces Additional Board Change
    • Notice of Special Meeting of Stockholders - March 17, 2010
    • Cardima Applies for Listing on NASDAQ Stock Market - Announces Shareholder Approval for Reverse Stock Split
    • Cardima Exhibits at HRS EP Tradeshow
    • Cardima's Surgical Ablation Probe Receives CE Mark Approval for the Surgical Treatment of Atrial Fibrillation
    • Cardima Announces Implementation of One-for-Ten Reverse Stock Split
  • SEC Filings
• Employment Opportunities
• Compliance